Capital Performance Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-90
Closed -$315 1002
2024
Q3
$315 Buy
+90
New +$315 ﹤0.01% 2446